Search research articles
Contact Us
Filters
Showing results (41-50 of 254) with videos related to
Page
of 26
Sort By:
Biochemistry
|
February 1, 1972
Peptide synthesis by means of tert-butyloxycarbonylamino acid derivatives of poly(ethylene-co-N-hydroxymaleimide)
M Fridkin, A Patchornik, E Katchalski
International Journal of Peptide and Protein Research
|
March 1, 1979
Facile thiolytic removal of the o-nitrophenylsulphenyl amino-protecting group
M Stern, A Warshawsky, M Fridkin
International Journal of Peptide and Protein Research
|
June 1, 1990
Thiolysis of the 3-nitro-2-pyridinesulfenyl (Npys) protecting group. An approach towards a general deprotection scheme in peptide synthesis
O Rosen, S Rubinraut, M Fridkin
Journal of Neural Transmission. Supplementum
|
April 24, 2007
Novel neuroprotective neurotrophic NAP analogs targeting metal toxicity and oxidative stress: potential candidates for the control of neurodegenerative diseases
H Zheng, D Blat, M Fridkin
Applied Optics
|
January 12, 2010
Anomalous shift of the absorption edge in ferroelectric BaTiO(3), under an electric field
V M Fridkin, K A Verkhovskaya
FEBS Letters
|
January 26, 1987
Binding of C-reactive protein to human neutrophils
R Buchta, M Pontet, M Fridkin
FEBS Letters
|
June 20, 2000
VIP and the potent analog, stearyl-Nle(17)-VIP, induce proliferation of keratinocytes
R Granoth, M Fridkin, I Gozes
International Journal of Peptide and Protein Research
|
February 1, 1995
The 2,4-dinitrophenyl group for protection of hydroxyl function of tyrosine during solid-phase peptide synthesis
R Philosof-Oppenheimer, I Pecht, M Fridkin
Biomedical Peptides, Proteins & Nucleic Acids : Structure, Synthesis & Biological Activity
|
January 1, 1996
Binding pockets on the surface of human leukocyte elastase and human leukocyte cathepsin G. Implications to the design of inhibitors derived from human C-reactive protein
E J Yavin, M Eisenstein, M Fridkin
Cellular and Molecular Neurobiology
|
December 1, 1995
A VIP hybrid antagonist: from developmental neurobiology to clinical applications
I Gozes, M Fridkin, D E Brenneman
Page
of 26
Search research articles
Search
Showing results (41-50 of 254) with videos related to
Sort By:
Page
of 26
Biochemistry
|
February 1, 1972
Peptide synthesis by means of tert-butyloxycarbonylamino acid derivatives of poly(ethylene-co-N-hydroxymaleimide)
M Fridkin, A Patchornik, E Katchalski
International Journal of Peptide and Protein Research
|
March 1, 1979
Facile thiolytic removal of the o-nitrophenylsulphenyl amino-protecting group
M Stern, A Warshawsky, M Fridkin
International Journal of Peptide and Protein Research
|
June 1, 1990
Thiolysis of the 3-nitro-2-pyridinesulfenyl (Npys) protecting group. An approach towards a general deprotection scheme in peptide synthesis
O Rosen, S Rubinraut, M Fridkin
Journal of Neural Transmission. Supplementum
|
April 24, 2007
Novel neuroprotective neurotrophic NAP analogs targeting metal toxicity and oxidative stress: potential candidates for the control of neurodegenerative diseases
H Zheng, D Blat, M Fridkin
Applied Optics
|
January 12, 2010
Anomalous shift of the absorption edge in ferroelectric BaTiO(3), under an electric field
V M Fridkin, K A Verkhovskaya
FEBS Letters
|
January 26, 1987
Binding of C-reactive protein to human neutrophils
R Buchta, M Pontet, M Fridkin
FEBS Letters
|
June 20, 2000
VIP and the potent analog, stearyl-Nle(17)-VIP, induce proliferation of keratinocytes
R Granoth, M Fridkin, I Gozes
International Journal of Peptide and Protein Research
|
February 1, 1995
The 2,4-dinitrophenyl group for protection of hydroxyl function of tyrosine during solid-phase peptide synthesis
R Philosof-Oppenheimer, I Pecht, M Fridkin
Biomedical Peptides, Proteins & Nucleic Acids : Structure, Synthesis & Biological Activity
|
January 1, 1996
Binding pockets on the surface of human leukocyte elastase and human leukocyte cathepsin G. Implications to the design of inhibitors derived from human C-reactive protein
E J Yavin, M Eisenstein, M Fridkin
Cellular and Molecular Neurobiology
|
December 1, 1995
A VIP hybrid antagonist: from developmental neurobiology to clinical applications
I Gozes, M Fridkin, D E Brenneman
Page
of 26